Diabetes and endocrinology
In this episode, Dr Yassir Javaid and Dr Janaka Karalliedde discuss the broad benefits of SGLT2 inhibitors from a cardio, renal and metabolic perspective and their impact on people living with type 2 diabetes.
- PC-GB-106690 | May 2022
- 7 May 2022
In this episode, Dr Kevin Fernando and Alia Gilani talk about the evidence for SGLT2 inhibitors in providing long-term outcomes for people living with type 2 diabetes.
- PC-GB-106689 | May 2022
- 7 May 2022